171 related articles for article (PubMed ID: 25741376)
1. Cyclin E2 is the predominant E-cyclin associated with NPAT in breast cancer cells.
Rogers S; Gloss BS; Lee CS; Sergio CM; Dinger ME; Musgrove EA; Burgess A; Caldon CE
Cell Div; 2015; 10():1. PubMed ID: 25741376
[TBL] [Abstract][Full Text] [Related]
2. The requirement for cyclin E in c-Myc overexpressing breast cancers.
Zhou Y; Geng Y; Zhang Y; Zhou Y; Chu C; Sharma S; Fassl A; Butter D; Sicinski P
Cell Cycle; 2020 Oct; 19(20):2589-2599. PubMed ID: 32975478
[TBL] [Abstract][Full Text] [Related]
3. Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1.
Caldon CE; Sergio CM; Burgess A; Deans AJ; Sutherland RL; Musgrove EA
Cell Cycle; 2013 Feb; 12(4):606-17. PubMed ID: 23324395
[TBL] [Abstract][Full Text] [Related]
4. Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer.
Caldon CE; Musgrove EA
Cell Div; 2010 Jan; 5():2. PubMed ID: 20180967
[TBL] [Abstract][Full Text] [Related]
5. Interaction of Heat Shock Protein Cpn10 with the Cyclin E/Cdk2 Substrate Nuclear Protein Ataxia-Telangiectasia (NPAT) Is Involved in Regulating Histone Transcription.
Ling Zheng L; Wang FY; Cong XX; Shen Y; Rao XS; Huang DS; Fan W; Yi P; Wang XB; Zheng L; Zhou YT; Luo Y
J Biol Chem; 2015 Dec; 290(49):29290-300. PubMed ID: 26429916
[TBL] [Abstract][Full Text] [Related]
6. Specific overexpression of cyclin E·CDK2 in early preinvasive and primary breast tumors in female ACI rats induced by estrogen.
Weroha SJ; Lingle WL; Hong Y; Li SA; Li JJ
Horm Cancer; 2010 Feb; 1(1):34-43. PubMed ID: 21761349
[TBL] [Abstract][Full Text] [Related]
7. Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells.
Caldon CE; Sergio CM; Kang J; Muthukaruppan A; Boersma MN; Stone A; Barraclough J; Lee CS; Black MA; Miller LD; Gee JM; Nicholson RI; Sutherland RL; Print CG; Musgrove EA
Mol Cancer Ther; 2012 Jul; 11(7):1488-99. PubMed ID: 22564725
[TBL] [Abstract][Full Text] [Related]
8. Cyclin E/CDK2: DNA Replication, Replication Stress and Genomic Instability.
Fagundes R; Teixeira LK
Front Cell Dev Biol; 2021; 9():774845. PubMed ID: 34901021
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclins E1 and E2 during mouse development and in neoplasia.
Geng Y; Yu Q; Whoriskey W; Dick F; Tsai KY; Ford HL; Biswas DK; Pardee AB; Amati B; Jacks T; Richardson A; Dyson N; Sicinski P
Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13138-43. PubMed ID: 11687642
[TBL] [Abstract][Full Text] [Related]
10. Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway.
Le XF; Bedrosian I; Mao W; Murray M; Lu Z; Keyomarsi K; Lee MH; Zhao J; Bast RC
Cell Cycle; 2006 Aug; 5(15):1654-61. PubMed ID: 16861913
[TBL] [Abstract][Full Text] [Related]
11. Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.
Caldon CE; Sergio CM; Sutherland RL; Musgrove EA
Cell Cycle; 2013 Feb; 12(4):596-605. PubMed ID: 23324394
[TBL] [Abstract][Full Text] [Related]
12. Cyclin E2 Promotes Whole Genome Doubling in Breast Cancer.
Lee C; Fernandez KJ; Alexandrou S; Sergio CM; Deng N; Rogers S; Burgess A; Caldon CE
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32823571
[TBL] [Abstract][Full Text] [Related]
13. Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.
Caldon CE; Sergio CM; Schütte J; Boersma MN; Sutherland RL; Carroll JS; Musgrove EA
Mol Cell Biol; 2009 Sep; 29(17):4623-39. PubMed ID: 19564413
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle dependent phosphorylation and subnuclear organization of the histone gene regulator p220(NPAT) in human embryonic stem cells.
Ghule PN; Becker KA; Harper JW; Lian JB; Stein JL; van Wijnen AJ; Stein GS
J Cell Physiol; 2007 Oct; 213(1):9-17. PubMed ID: 17520687
[TBL] [Abstract][Full Text] [Related]
15. Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins.
Zariwala M; Liu J; Xiong Y
Oncogene; 1998 Nov; 17(21):2787-98. PubMed ID: 9840943
[TBL] [Abstract][Full Text] [Related]
16. Cx43 and AKAP95 regulate G1/S conversion by competitively binding to cyclin E1/E2 in lung cancer cells.
Chen R; Chen Y; Yuan Y; Zou X; Sun Q; Lin H; Chen X; Liu M; Deng Z; Yao Y; Guo D; Zhang Y
Thorac Cancer; 2020 Jun; 11(6):1594-1602. PubMed ID: 32338437
[TBL] [Abstract][Full Text] [Related]
17. Loss of cyclin E requirement in cell growth of an oral squamous cell carcinoma cell line implies deregulation of its downstream pathway.
Yamada S; Sumrejkanchanakij P; Amagasa T; Ikeda MA
Int J Cancer; 2004 Aug; 111(1):17-22. PubMed ID: 15185338
[TBL] [Abstract][Full Text] [Related]
18. AKAP95 promotes cell cycle progression via interactions with cyclin E and low molecular weight cyclin E.
Kong XY; Zhang DC; Zhuang WX; Hua SH; Dai Y; Yuan YY; Feng LL; Huang Q; Teng BG; Yu XY; Liu WZ; Zhang YX
Am J Transl Res; 2016; 8(2):811-26. PubMed ID: 27158371
[TBL] [Abstract][Full Text] [Related]
19. CDK inhibitors selectively diminish cell cycle controlled activation of the histone H4 gene promoter by p220NPAT and HiNF-P.
Mitra P; Ghule PN; van der Deen M; Medina R; Xie RL; Holmes WF; Ye X; Nakayama KI; Harper JW; Stein JL; Stein GS; van Wijnen AJ
J Cell Physiol; 2009 May; 219(2):438-48. PubMed ID: 19170105
[TBL] [Abstract][Full Text] [Related]
20. HiNF-P directly links the cyclin E/CDK2/p220NPAT pathway to histone H4 gene regulation at the G1/S phase cell cycle transition.
Miele A; Braastad CD; Holmes WF; Mitra P; Medina R; Xie R; Zaidi SK; Ye X; Wei Y; Harper JW; van Wijnen AJ; Stein JL; Stein GS
Mol Cell Biol; 2005 Jul; 25(14):6140-53. PubMed ID: 15988025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
